TOC dettagliato di approfondimenti sul mercato della medicina personalizzata globale, previsto per il 2029
1 Panoramica del rapporto
1.1 Ambito da studio
1.1 Analisi di mercato per tipo
1.2.1 Medicina personalizzata Global Dimensione del mercato Tale di crescita per tipo, 2018 vs 2024 vs 2029
1.2.2 Medicine personalizzata Diagnostica
1.2.3 Cure mediche personalizzate
1.12.4 Medicine personalizzata terapeutica
2. Wellness
1.3 Mercato per applicazione
1.3.1 Tasso di crescita del mercato della medicina personalizzata per l'applicazione, 2018 vs 2024 vs 2029
1.3.2 Oncologia
1.3.3 Sistema nervoso centrale (CNS)
1.3.4 Immunologia
1.3.3.5 />1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine Market Perspective (2018-2029)
2.2 Global Personalized Medicine Growth Trends by Region
2.2.1 Personalized Medicine Market Size by Region: 2018 VS 2024 VS 2029
2.2.2 Personalized Medicine Historic Market Size by Region (2018-2024)
2.2.3 Personalized Medicine Forecasted Market Size by Region (2024-2029)
2.3 Personalized Medicine Market Dynamics
2.3.1 Personalized Medicine Industry Trends
2.3.2 Personalized Medicine Market Drivers
2.3.3 Personalized Medicine Market Challenges
2.3.4 Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Personalized Medicine by Players
3.1.1 Global Personalized Medicine Revenue by Players (2018-2024)
3.1.2 Global Personalized Medicine Revenue Market Share by Players (2018-2024)
3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Personalized Medicine, Ranking by Revenue, 2021 VS 2024 VS 2024
3.4 Global Personalized Medicine Market Concentration Ratio
3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2024
3.5 Global Key Players of Personalized Medicine Head office and Area Served
3.6 Global Key Players of Personalized Medicine, Product and Application
3.7 Global Key Players of Personalized Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine Breakdown Data by Type
4.1 Global Personalized Medicine Historic Market Size by Type (2018-2024)
4.2 Global Personalized Medicine Forecasted Market Size by Type (2024-2029)
5 Personalized Medicine Breakdown Data by Application
5.1 Global Personalized Medicine Historic Market Size by Application (2018-2024)
5.2 Global Personalized Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Personalized Medicine Market Size (2018-2029)
6.2 North America Personalized Medicine Market Size by Type
6.2.1 North America Personalized Medicine Market Size by Type (2018-2024)
6.2.2 North America Personalized Medicine Market Size by Type (2024-2029)
6.2.3 Nord America Nord di mercato di mercato di Medicina per tipo (2018-2029)
6.3 Nord America Dimensione del mercato della medicina personalizzata per applicazione
6.3.1 Nord America Medicine Personalizzati Dimensione del mercato di Medicina per applicazione (2018-2024)
6.3.3.3.2 North America Dimensione del mercato della medicina personalizzata (2024-20. (2018-2029)
6.4 North America Personalized Medicine Market Size by Country
6.4.1 North America Personalized Medicine Market Size by Country: 2018 VS 2024 VS 2029
6.4.2 North America Personalized Medicine Market Size by Country (2018-2024)
6.4.3 North America Personalized Medicine Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Personalized Medicine Market Size (2018-2029)
7.2 Europe Personalized Medicine Market Size by Type
7.2.1 Europe Personalized Medicine Market Size by Type (2018-2024)
7.2.2 Europe Personalized Medicine Market Size by Type (2024-2029)
7.2.3 Europe Personalized Medicine Market Share by Type (2018-2029)
7.3 Europe Personalized Medicine Market Size by Application
7.3.1 Europe Personalized Medicine Market Size by Application (2018-2024)
7.3.2 Europe Personalized Medicine Market Size by Application (2024-2029)
7.3.3 Europe Personalized Medicine Market Share by Application (2018-2029)
7.4 Europe Personalized Medicine Market Size by Country
7.4.1 Europe Personalized Medicine Market Size by Country: 2018 VS 2024 VS 2029
7.4.2 Europe Personalized Medicine Market Size by Country (2018-2024)
7.4.3 Europe Personalized Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Personalized Medicine Market Size (2018-2029)
8.2 China Personalized Medicine Market Size by Type
8.2.1 China Personalized Medicine Market Size by Type (2018-2024)
8.2.2 China Personalized Medicine Market Size by Type (2024-2029)
8.2.3 China Personalized Medicine Market Share by Type (2018-2029)
8.3 China Personalized Medicine Market Size by Application
8.3.1 China Personalized Medicine Market Size by Application (2018-2024)
8.3.2 China Personalized Medicine Market Size by Application (2024-2029)
8.3.3 China Personalized Medicine Market Share by Application (2018-2029)
9 Asia (esclusa la Cina)
9.1 Asia Dimensioni del mercato della medicina personalizzata (2018-2029)
9.2 Dimensione del mercato della medicina personalizzata dell'Asia per tipo
9.2.1 Asia Dimensioni del mercato personalizzato di medicina per tipo (2018-2024)
9.2.2.2.2.2 Asia Medicine Personalized Market Dimensioni di mercato per tipo (2024-2029)
9.3.3 ASIA di mercato personalizzato per tipo (2018-202) />9.3 Asia Personalized Medicine Market Size by Application
9.3.1 Asia Personalized Medicine Market Size by Application (2018-2024)
9.3.2 Asia Personalized Medicine Market Size by Application (2024-2029)
9.3.3 Asia Personalized Medicine Market Share by Application (2018-2029)
9.4 Asia Personalized Medicine Market Size by Region
9.4.1 Asia Personalized Medicine Market Size by Region: 2018 vs 2024 vs 2029
9.4.2 Dimensione del mercato della medicina personalizzata in Asia per regione (2018-2024)
9.4.3 Asia Dimensione del mercato della medicina personalizzata per regione (2024-2029)
9.4.4 Giappone
9.4.5.5.5 Corea del Sud
9.4.4 China Taiwan
9.7 ASIA
8
Br />9.4.5.5.4.5 Corea del Sud
.4.4.4 China Taiwan
9.7 ASIA
Australia
10 Medio Oriente, Africa e America Latina
10.1 Medio Oriente, Africa e America Latina Dimensioni del mercato della medicina (2018-2029)
10.2 Medio Oriente, Africa e America Latina Dimensioni del mercato di medicina personalizzata per tipo
10.2.1 Middle Oriente, Africa e Africa America Latina Dimensione del mercato di Medicina (2018-2024)
10.2.3 Middle East, Africa, and Latin America Personalized Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Personalized Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Personalized Medicine Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Dimensione del mercato della medicina personalizzata per applicazione (2024-2029)
10.3.3 Medio Oriente, Africa e America Latina quota di mercato della medicina personalizzata per applicazione (2018-2029)
10.4 Medio Oriente, Africa e America Latina Dimensione del mercato di medicina
10.4.4.4.1.1.1.1 Middle East, Middle East Middle East, 2018 VS 2024 VS 2029
10.4.3 Middle East, Africa, and Latin America Personalized Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Personalized Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business ; (2018-2024)
11.2.5 Agilent Technologies Recenti sviluppi
11.3 Amgen
11.3.1 Dettagli dell'azienda AMGEN
11.3.2 Amgen Panoramica azienda />11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Personalized Medicine Introduction
11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2018-2024)
11.4.5 Astellas Pharma Recent Developments
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Personalized Medicine Introduction
11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2018-2024)
11.5.5 Astrazeneca Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Personalized Medicine Introduction
11.6.4 Bayer AG Revenue in Personalized Medicine Business (2018-2024)
11.6.5 Bayer AG Recent Developments
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Panoramica
11.7.3 Celgene Corporation Introduzione di medicina personalizzata
11.7.4 Revenue della Celgene Corporation in Medicine Personalized (2018-2024)
11.7.5 Celgene Corporation Recenti sviluppi
111.8 Glaxosmithkline Plc
11.8.1 GlaxoSmithKline PLC Panoramica aziendale
11.8.3 GlaxoSmithKline PLC Medicine personalizzata Introduzione
11.8.4 GlaxoSmithKline PLC Revenue in Personalized Medicine Business (2018-2024)
111.8.5 GlaxoSmithKline Plc Recenti sviluppi
111.9 Illumina
11.9.3 Illumina Personalized Medicine Introduction
11.9.4 Illumina Revenue in Personalized Medicine Business (2018-2024)
11.9.5 Illumina Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Introduzione alla medicina personalizzata
11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2018-2024)
11.10.5 Corporation Medicine personalizzata Introduzione
11.11.4 Levendito della società di laboratorio in attività di medicina personalizzata (2018-2024)
11.11.5 Laboratorio Corporation Recenti sviluppi
11.12 Merck
11.12.12.1 Dettagli della società Merck
11.12.22.22.22.22.2.4 BR /> Merck Revenue in Personalized Medicine Business (2018-2024)
11.12.5 Recenti sviluppi di Merck
11.13 Novartis Ag
11.13.13.1 Novartis AG Dettagli della società
11.13.2 Novartis RevAGIS AG BUSINESS AGE AGE AGE AGE BR /Br />11.13.3 Novartis Personalized Medicine Introduzione
; (2018-2024)
11.14.5 Roche Holding Ag Recenti sviluppi
11.15 Siemens AG
11.15.1 Siemens Dettagli della società
11.15.2 Siemens Ag Business Overwy
11.15.3 SIEMENS Ag Introduzione di medicina personalizzata
15.15.4 SIEMENS AG BUSINESS BUSINESS (2018-2024)
11.15.5 Siemens AG Recenti sviluppi
11.16 Takeda Pharmaceutical Company Limited
11.16.1 Takeda DETTAGLIO DI SOCIETÀ PARMACEUTICA LIMITED
16.16.2 Takeda Pharmaceutical Company Limited Business />11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2018-2024)
11.16.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Dettagli dell'autore
